Jean Jacques Bienaime - Oct 14, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Oct 14, 2022
Transactions value $
-$359,560
Form type
4
Date filed
10/18/2022, 08:01 PM
Previous filing
Aug 16, 2022
Next filing
Nov 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$360K -4K -1.22% $89.89 324K Oct 14, 2022 Direct F1
holding BMRN Common Stock 248K Oct 14, 2022 Shares held by Jean-Jacques Bienaime Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on May 3, 2022.